Featured ArticlesJDD HighlightsLatest News

JDD December Highlights and Editor Picks

By December 19, 2025No Comments

Curated by the JDD Editors

Missed any of our December highlights? December is our Immunodermatology issue and it’s packed with intriguing articles–start to dive in! Catch up with this curated roundup from the JDD Editors: Your guide to must-read articles for the derm community.

DECEMBER’S ISSUE

GLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities  reviews emerging evidence and existing literature on GLP-1RAs and their applications.

Evaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study  underscores the importance of recognizing inflammatory skin conditions as markers of systemic inflammation.

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne: A Pooled Analysis by Age  shares the results of the only approved triple-combination, fixed-dose, topical acne treatment.

Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis  evaluates the association between isotretinoin therapy and the risk of IBD using a large real-world database.

An Open-Label, Single-Center Proof of Concept Study Evaluating the Efficacy and Safety of Tirzepatide for Moderate to Severe Hidradenitis Suppurativa  shows promising efficacy and tolerability in patients with moderate-to-severe HS and obesity.

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation  supports the use of Thiamidol-containing formulations as part of the overall management strategy.

Skin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments assesses the biological effects of this moisturizer on key epidermal proteins of skin barrier function.

The Current Landscape of Treatment of Warts  explores current literature and expresses the need for updates to the current wart treatments through larger clinical trials.

Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting discusses key research advancements in psoriatic disease, hidradenitis suppurativa, geriatric dermatology, connective tissue disease, vitiligo, itch, actinic keratosis, acne, and cutaneous T-cell lymphoma.

Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis  evaluates the association between isotretinoin therapy and the risk of IBD using a large real-world database.

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation  supports the use of Thiamidol-containing formulations as part of the overall management strategy.

Resolution of Lichen Simplex Chronicus With Nemolizumab: A Case Report  shares the promising results of a 52-year-old patient suffering from this ailment.

Disparities in Hidradenitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024